ClinicalTrials.govpublic full text
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
retinitis pigmentosa, cnga1 mutation, aav2, gene therapy, eye disease, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 847603
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.